Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Are the Projected Expansion Rates of the Branded Generics Market for the Next Decade?

The size of the branded generics market has seen significant growth in the past few years. The market, which is expected to expand from $363.49 billion in 2024 to $397.19 billion in 2025, will experience a compound annual growth rate (CAGR) of 9.3%. The notable growth in the previous years can be linked to factors such as cost-efficiency, patent expiries, wider market access, government policies and initiatives, as well as healthcare reforms.

In the coming years, the branded generics market is anticipated to experience swift expansion, increasing to a projected size of $601.4 billion by 2029 with a compound annual growth rate (CAGR) of 10.9%. This projected growth could be due to factors such as an increased demand for generic biologics, a rise in chronic diseases, the growth of nascent markets, and an emphasis on biosimilars. During the forecast period, prominent trends expected to emerge include strategic alliances and cooperation, technological progress, a concentration on chronic diseases, market stabilization and consolidation, and a patient-focused strategy.

What External and Internal Drivers Are Contributing to the Growth of the branded generics Market’s Growth?

The growth trajectory of the branded generics market is expected to be propelled by the escalating incidence of chronic diseases. These diseases, which persist over time and often have no cure, can nonetheless be managed and treated. Their occurrence is rising due to factors like the increasing consumption of tobacco, poor dietary habits, physical inactivity, and excessive alcohol use, among others. Globally, customers are showing a growing preference for branded generics in managing chronic illnesses due to their lower cost compared to regular medications. For example, the World Health Organization (WHO) 2022 Highlights, a report by the Switzerland-based intergovernmental health body, cited in September 2022 that 41 million, or 74% of all deaths worldwide, were attributed to noncommunicable diseases (NCDs) or chronic diseases annually. Therefore, the surging prevalence of chronic diseases is envisaged to stimulate the demand for branded generics throughout the forecasted period.

Get Your Free Sample of the Global Branded Generics Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=7186&type=smp

Which Companies Are Redefining the Future of the Branded Generics Market?

Major companies operating in the branded generics market include:

• Pfizer Inc._x000D_

• F. Hoffmann-La Roche AG_x000D_

• Sanofi SA_x000D_

• AstraZeneca plc_x000D_

• GlaxoSmithKline plc_x000D_

What Trends Are Poised to Drive the Future Success of the Branded Generics Market?

The trend of strategic alliances is significant within the branded generics market. Companies functioning in this market are partnering with related businesses to capitalize on one another’s resources, thereby expanding their reach into fresh markets. To illustrate, Biocon Ltd., a pharmaceutical firm from India, entered into a collaboration with Tabuk Pharmaceuticals in September 2024. Biocon’s role will involve the production and development of GLP-1 products, ensuring premium biopharmaceuticals specific to the treatment of diabetes. Conversely, Tabuk Pharmaceuticals will possess the rights for marketing authorization, while also managing the registration, importing and promotion of these items primarily in Saudi Arabia, which is located in the Middle East. The deal is inclusive of potential growth prospects into additional GLP items beyond the preliminary offerings, making way for a more comprehensive selection of diabetes care treatments. The primary objective of the partnership is to provide distinctive health solutions augmenting the well-being of residents in Saudi Arabia and adjoining regions, in sync with the healthcare accessibility improvement goals of both entities. Tabuk Pharmaceuticals operates its business based out of Saudi Arabia and promotes its line of branded and generic pharmaceutical goods.

Get Instant Access to the Global Branded Generics Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/branded-generics-global-market-report

Which Key Market Segments Comprise the Branded Generics Market and Drive Its Revenue Growth?

The branded generics market covered in this report is segmented –

1) By Drug Class: Alkylating Agents, Antimetabolites, Hormones, Anti-Hypertensive, Lipid Lowering Drugs, Anti-Depressants, Anti-Psychotics, Anti-Epileptics, Other Drugs

2) By Route Of Administration: Topical, Oral, Parenteral, Other Routes Of Administration

3) By Application: Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics And Anti-inflammatory, Other Applications

Subsegments:

1) By Alkylating Agents: Nitrogen Mustards, Ethylene Imine Compounds

2) By Antimetabolites: Purine Analogues, Pyrimidine Analogues

3) By Hormones: Corticosteroids, Thyroid Hormones

4) By Anti-Hypertensive: ACE Inhibitors, Beta Blockers, Calcium Channel Blockers

5) By Lipid Lowering Drugs: Statins, Fibrates

6) By Anti-Depressants: SSRIs (Selective Serotonin Reuptake Inhibitors), SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)

7) By Anti-Psychotics: Atypical Antipsychotics, Typical Antipsychotics

8) By Anti-Epileptics: Sodium Channel Blockers, GABAergic Drugs

9) By Other Drugs: Analgesics, Antibiotics, Antivirals

What Are the Leading Regions in the Branded Generics Market Expansion?

North America was the largest region in the branded generics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the branded generics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Can We Define the Branded Generics Market and Its Key Components?

Branded generics refer to an unregistered drug that is marketed under a brand name and provides patients and healthcare providers with a benefit that encourages them to choose the brand. These are the generic medications that have a unique brand name on the market. They might be advertised similarly to how branded medications are.

Browse Through More Similar Reports By The Business Research Company:

Gastrointestinal Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Pharmacies and Drug Stores Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmacies-and-drug-stores-global-market-report

Vitamin and Minerals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/vitamin-and-mineral-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: